Article

Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay

2024-08-10

Abstract excerpt

<title>Abstract</title> <p>Background Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. Early detection of precursor lesions or early-stage cancer could hamper cancer development or improve survival rates. Liquid biopsy, which detects tumor biomarkers, such as mutations, in blood, is a promising avenue for cancer screening. Aim To assess the presence of genetic variants in plasma ce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c6d05fc4-e3f3-5403-9d4a-4ed782ba616e
DOI: 10.21203/rs.3.rs-4694299/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA AssayDOI 10.21203/rs.3.rs-4694299/v1Read

Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay.Semantic proximity Read

Genomic Profiling Filtering and Molecular Analysis of Colorectal Cancer (CRC) using Next Generation Sequencing (NGS): Identifying Somatic Mutations Biomarkers and Patterns for Precision MedicineSemantic proximity Read

Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancer.Semantic proximity Read

Mutational landscape of plasma cell-free DNA identifies molecular features associated with therapeutic response in patients with colon cancer. A pilot study.Semantic proximity Read

Somatic targeted mutation profiling of colorectal cancer precursor lesionsSemantic proximity Read

Molecular characterization of colorectal cancer (CRC) using next generation sequencing (NGS) in bridging the gap between research and clinical practice: from biomarker discovery to clinical implementationSemantic proximity Read

Comparative Study of Mutations in Single Nucleotide Polymorphism Loci of KRAS and BRAF Genes in Patients Who Underwent Screening Colonoscopy, With and Without Premalignant Intestinal Polyps.Semantic proximity Read

Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancerSemantic proximity Read

Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon CancerSemantic proximity Read

Integrating cfDNA Liquid Biopsy and Organoid-Based Drug Screening Reveals PI3K Signaling as a Promising Therapeutic Target in Colorectal CancerSemantic proximity Read

Genetic-Based Biomarkers and Next-Generation Sequencing: The Future of Personalized Care in Colorectal CancerSemantic proximity Read

Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics.Semantic proximity Read